Clinical Trials Logo

Filter by:
NCT ID: NCT04821635 Recruiting - Clinical trials for Spinal Cord Injuries

Effects of FES-Rowing in Neurological Disorders (FES-ROW)

FES-ROW
Start date: April 2024
Phase: N/A
Study type: Interventional

The main objective of this project is to measure the increase in aerobic physical and metabolic capacities with a 6-month training on a rower assisted by electrostimulation of lower limbs in a population of adults with traumatic paraplegia.

NCT ID: NCT04821622 Active, not recruiting - Prostate Cancer Clinical Trials

Study of Talazoparib With Enzalutamide in Men With DDR Gene Mutated mCSPC

Start date: May 12, 2021
Phase: Phase 3
Study type: Interventional

The purpose of the study is to evaluate the safety and efficacy of talazoparib in combination with enzalutamide compared with placebo in combination with enzalutamide in participants with DDR-deficient mCSPC.

NCT ID: NCT04821596 Recruiting - Multiple Sclerosis Clinical Trials

Study of the Mechanisms of Action of Cladribine in Multiple Sclerosis

Clad'Action
Start date: July 13, 2020
Phase: N/A
Study type: Interventional

The main objective of the project is therefore to study and thus better understand the immunomodulatory / anti-inflammatory effects of cladribine during multiple sclerosis. Most current and developing therapies targeting the immune system have no effect on the progressive phase of MS, during which neurodegeneration plays a predominant role. As mentioned above, the very promising results of clinical trials with cladribine tablets for the early and progressive phase of the disease have revealed immunomodulatory properties and suggested potential neuroprotective effects. It therefore plans to further dissect one of these two parameters by designing in vitro studies with peripheral blood mononuclear cells (PBMC) from healthy donors and MS patients.

NCT ID: NCT04821440 Recruiting - Lymphedema Clinical Trials

A 3D Tablet Sensor Approach to the Measurement of a Lymphedema

LO3D
Start date: June 16, 2021
Phase: N/A
Study type: Interventional

Up to now, the diagnosis of lymphedema remains hard and delayed. It suffers from many limitations such as lack of coordination and formation of the health-care network. The diversity of used tools is another obstacle because all provided solutions on the market are either costless with poor accuracy, or highly expensive but with excellent accuracy. Therefore, we decided to evaluate an affordable and open-source 3D iPad sensor sharing the same technology used in Kinect sensors.

NCT ID: NCT04821336 Completed - Thyroid Cancer Clinical Trials

Cholesterol Metabolites Analysis in Human Thyroid and Iodine Resistance

OXYTHYR
Start date: April 15, 2021
Phase:
Study type: Observational

The study team previously shown that a cholesterol metabolite, dendrogenin A (DDA) differentiates anaplastic thyroid cancer cell lines and that its mRNA expression is diminished in human radioiodine refractory thyroid cancer samples. The team aim to quantify via mass spectrometry and immunohistochemistry DDA and other cholesterol metabolites in thyroid cancer versus healthy thyroid tissue human samples.

NCT ID: NCT04821128 Recruiting - Cell Carcinoma Clinical Trials

Radio/Pathological Evaluation of Tongue Cancer Infiltration

RaP E ToC
Start date: November 27, 2020
Phase:
Study type: Observational

The aim of the study is to assess the good correlation and prediction of the DOI for the post-operative pathological results and prognosis.

NCT ID: NCT04821115 Recruiting - Peyronie Disease Clinical Trials

Safety and Efficacy of Low-intensity Shockwave Therapy for Peyronie's Disease

ONDELA
Start date: April 6, 2021
Phase: N/A
Study type: Interventional

Investigation of the effect of Low-intensity extracorporeal shockwave therapy (ESWT) for Peyronie's disease (PD) via a single blind, sham-controlled, randomized clinical trial. Investigators will not be blinded to group assignments, but penile curvature will be assessed from coded patient pictures by a blinded assessor.

NCT ID: NCT04821089 Recruiting - Clinical trials for Moderate to Severe Upper Facial Lines

A Study to Assess the Safety and Efficacy of IPN10200 in Adult Participants With Moderate to Severe Upper Facial Lines

LANTIC
Start date: April 6, 2021
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this study is to assess the safety and efficacy profile of increasing doses of IPN10200 in comparison to placebo, with the aim to discover the doses(s) that offer the best efficacy/safety profile when used for the treatment of moderate to severe Upper Facial Lines. This study will be conducted in three stages. The full study (including all stages) will have a maximum 547 participants. The protocol is currently approved up to stage 1, step 1 and stage 1/ step 2. Stage 1 (phase Ib & II) - Step 1 (Phase Ib): a dose-escalation first-in-human step in participants with moderate to severe Glabellar Lines (GL) - Step 2 (Phase II): dose finding step in participants with moderate to severe GL as compared with Dysport Stage 2 (phase II) - An evaluation of efficacy and safety of IPN10200 in one of the following regions: GL + forehead lines (FHL) or lateral canthal lines (LCL) Stage 3 (phase II) - A safety and efficacy evaluation of IPN10200 in all three regions (GL, FHL and LCL)

NCT ID: NCT04821011 Completed - Premature Birth Clinical Trials

Assessment of Autonomic Regulation During the Listening of Mother Heart Beat in Newborns

Cardio_Sound
Start date: April 23, 2021
Phase:
Study type: Observational

Prematurity birth lead to an early breaking link with the in utero environment. A special attention is brought in the neonatal intensive care units to reduce noise and lighting surrounding aiming to protect the newborn. During the uterine life fetus benefits previously of several auditory stimulations by the maternal voice, the mother's heartbeat. After birth the auditory environment is dramatically modified. Aim of this study is to submit to the newborn an audio recording of his mother's heart beat to analyze the comfort, stress and autonomic response. Heart rate variability (HRV) analysis is a non-invasive tool able to consider autonomic nervous system activity. Previous studies have shown that pleasant feelings are associated with an increase of high frequencies variations index (HFnu index) reflecting a prevalence of parasympathetic activity in the sympathetic-parasympathetic balance. This one can be simply assess by a monitor named NIPĪ£ and can provide a comfort index by quantifying the parasympathetic tone.

NCT ID: NCT04820998 Completed - Autistic Disorder Clinical Trials

Living in a Precarious Situation With an Autistic Child: What Are the Issues at Stake for Support in Care

HaSPrEA
Start date: September 1, 2021
Phase:
Study type: Observational

Study the specificities of families in a precarious situation with a child with autism spectrum disorders (ASD) in terms of housing, in order to better support them in the various social spaces and improve collaboration between professionals and parents